Appeals court upholds AngioDynamics injunction, $160m penalty against Biolitec

A federal appeals court issues a pair of wins to AngioDynamics in its long-running dispute with former partner Biolitec, including some $160 million in fines, but remands a portion of the case to cap the penalties.

Biolitec, AngioDynamics Inc.

Legal News, News Well, Vascular

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1MumWgd